Search

Your search keyword '"Ratjen, Felix"' showing total 1,493 results

Search Constraints

Start Over You searched for: Author "Ratjen, Felix" Remove constraint Author: "Ratjen, Felix"
1,493 results on '"Ratjen, Felix"'

Search Results

2. Reply to Eker et al. Comment on Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704.

4. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.

5. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

6. De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia

7. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

11. Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation

12. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

13. Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial

16. Effects of elexacaftor/tezacaftor/ivacaftor therapy in children with cystic fibrosis – a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI

17. Genotype-Phenotype Correlations in Children with HHT.

19. Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

21. High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification

24. The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial

25. Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease

27. Effects of Traffic-Related Air Pollution on Exercise Endurance, Dyspnea, and Cardiorespiratory Responses in Health and COPD: A Randomized, Placebo-Controlled, Crossover Trial

29. Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis

34. PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy

37. Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

38. Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis

42. The future of cystic fibrosis care: a global perspective

47. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial

49. Eradication of early P. aeruginosa infection in children

50. The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF

Catalog

Books, media, physical & digital resources